CDER Move To White Oak Site Delayed Until July
This article was originally published in The Pink Sheet Daily
Executive Summary
The move, which had been scheduled for April, has been pushed back because the building is not ready, FDA says. The CDER reorganization is also being delayed to coincide with the move.
You may also be interested in...
FDA Oncology Office Director Will Be Selected In Next Few Weeks
The selection of a director for the new Office of Oncology Drug Products will be finalized in the next few weeks, FDA said